SIRT7-expression measurements in bone marrow leukocytes of AML at diagnosis showed a higher SIRT7-expression in prognostic favorable FLT3-ITD-negative AML samples in comparison to FLT3-ITD-mutated AML samples. The gene discussed is FLT3; the disease is acute myeloid leukemia.